Clinical TrialsSearch results
Number of results: 237
Other
- A randomized trial of lamivudine continuous therapy and entecavir switching therapy for chronic hepatitis B patients treated with lamivudine monotherapy
- Chronic hepatitis B
- Nagoya City University Hospital
- 2008-04-16
Other
- Assessment of Beta-Blocker Treatment in Japanese Patients with Chronic Heart Failure
- Chronic heart failure
- J-CHF Study Group
- 2006-12-13
Other
- A multicenter, randomized open trial of ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A
- Charcot-Marie-Tooth disease 1A
- New treatment strategies for intractable neuropathies based on its pathomechanism. The Research Grant 19A-5 for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare.
- 2009-01-01
Other
- Observational Registry:Gastrointestinal Complications developed during low-dose aspirin intake or atherothrombosis such as myocardial infarction and cerebral infarction-
- Cerebral infarction, TIA, angina, myocardial infarction, atrial fibrillation
- Society for the MAGIC
- 2007-07-01
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)
- Carcinoma of Unknown Primary Sites
- Kyushu Medical Oncology Group
- 2008-09-09
Other
- A Phase I/II Study of Vinorelbine plus Trastuzumab in Patients with Advanced/Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-07-13
Other
- Capecitabine/cyclophosphamide combination therapy for patients with advanced or metastatic breast cancer who have been previously treated with anthracyclines - a phase 2 study
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2005-07-07
Other
- Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17
Other
- Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17